Endra Life Sciences Inc. received notice of delisting from The Nasdaq Capital Market due to failure to comply with the Minimum Bid Price Requirement, and has requested a hearing to appeal the delisting determination.
AI Assistant
ENDRA LIFE SCIENCES INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.